Halozyme Therapeutics Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2014
Total Assets: $166.0M
Liabilities Breakdown FY2014
Total Liabilities: $124.6M
Asset Breakdown
Total Assets: $166.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $61.4M | 37.0% |
| Accounts Receivable | $9.1M | 5.5% |
| Inventory | $6.4M | 3.9% |
| Property, Plant & Equipment | $3.0M | 1.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $86.1M | 51.9% |
Liabilities Breakdown
Total Liabilities: $124.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.0M | 2.4% |
| Long-Term Debt | $49.9M | 40.0% |
| Other Liabilities | $71.8M | 57.6% |